tiprankstipranks
Ovid Therapeutics Inc (OVID)
NASDAQ:OVID
US Market
OVID
Ovid Therapeutics
RESEARCH TOOLSreports
Want to see OVID full AI Analyst Report?

Ovid Therapeutics (OVID) Income Statement

1,756 Followers

Ovid Therapeutics Income Statement

Last quarter (Q1 2026), Ovid Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Ovid Therapeutics's net income was $-16.99M. See Ovid Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 7.25M$ 566.00K$ 392.00K$ 1.50M$ 208.38M
Gross Profit
$ 6.95M$ 566.00K$ 392.00K$ 1.50M$ 208.38M
Operating Expenses
$ 49.39M$ 62.45M$ 59.67M$ 57.05M$ 84.17M
Depreciation and Amortization
$ 300.00K$ 613.00K$ 568.00K$ 1.38M$ 237.08K
EBITDA
$ -42.14M$ -57.77M$ -57.01M$ -54.17M$ 124.45M
Operating Income
$ -42.44M$ -61.88M$ -59.28M$ -55.55M$ 124.21M
Other Income/Expenses
$ 25.02M$ 35.45M$ 6.94M$ 1.38M$ -45.69K
Pretax Income
$ -17.41M$ -26.43M$ -52.34M$ -54.17M$ 124.16M
Net Income
$ -17.41M$ -26.43M$ -52.34M$ -54.17M$ 122.83M
Per Share Metrics
Basic EPS
$ -0.24$ -0.37$ -0.74$ -0.77$ 1.78
Diluted EPS
$ -0.24$ -0.37$ -0.74$ -0.77$ 1.76
Weighted Average Shares Outstanding
 73.74M 70.91M 70.58M 70.42M 67.48M
Weighted Average Shares Outstanding (Diluted)
 73.74M 70.91M 70.58M 70.42M 68.07M
Currency in USD

Ovid Therapeutics Earnings and Revenue History